Detalles de la búsqueda
1.
Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer.
J Clin Oncol
; 41(9): 1638-1645, 2023 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36921335
2.
Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer.
J Clin Oncol
; 41(13): 2305-2312, 2023 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37126944
3.
The clinical benefit of bevacizumab in metastatic colorectal cancer is independent of K-ras mutation status: analysis of a phase III study of bevacizumab with chemotherapy in previously untreated metastatic colorectal cancer.
Oncologist
; 14(1): 22-8, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19144677
4.
High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants.
Nat Med
; 25(12): 1928-1937, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31768066
5.
Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer.
J Clin Oncol
; 23(15): 3502-8, 2005 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-15908660
6.
Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial.
J Clin Oncol
; 23(16): 3697-705, 2005 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15738537
7.
Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer.
J Clin Oncol
; 21(1): 60-5, 2003 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12506171
8.
Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer.
J Clin Oncol
; 20(3): 719-26, 2002 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11821453
9.
Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer.
J Clin Oncol
; 22(11): 2184-91, 2004 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15169807
10.
A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer.
Semin Oncol
; 30(5 Suppl 16): 117-24, 2003 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-14613032
11.
Impact of vascular endothelial growth factor-A expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizumab in metastatic colorectal cancer.
J Clin Oncol
; 24(2): 217-27, 2006 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-16365183
12.
Association of k-ras, b-raf, and p53 status with the treatment effect of bevacizumab.
J Natl Cancer Inst
; 97(13): 981-9, 2005 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-15998951
Resultados
1 -
12
de 12
1
Próxima >
>>